Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CVRX - CVRx, Inc.

IEX Last Trade
13.335
-0.165   -1.237%

Share volume: 323
Last Updated: Fri 27 Dec 2024 04:29:05 PM CET
Surgical and Medical Instrument Manufacturing : -0.37%

PREVIOUS CLOSE
CHG
CHG%
$13.50
-0.17
-1.22%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
27%
Profitability 25%
Dept financing 14%
Liquidity 75%
Performance 21%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.20%
1 Month
-15.69%
3 Months
52.84%
6 Months
15.49%
1 Year
-58.44%
2 Year
-25.22%
Key data
Stock price
$13.34
P/E Ratio 
-3.95
DAY RANGE
$13.49 - $13.50
EPS 
-$2.58
52 WEEK RANGE
$6.96 - $33.14
52 WEEK CHANGE
-$60.92
MARKET CAP 
214.807 M
YIELD 
N/A
SHARES OUTSTANDING 
21.786 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
1.50
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$171,692
AVERAGE 30 VOLUME 
$169,722
Company detail
CEO: Nadim Yared
Region: US
Website: cvrx.com
Employees: 160
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

CVRx, Inc. focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe and internationally.

Recent news